Nov 11 (Reuters) - Australia's Sigma Healthcare's
top shareholder HMC Capital has cut its stake in the company, days after the country's competition watchdog gave its nod to pharmacy chain Chemist Warehouse's backdoor listing via Sigma.
HMC Capital has trimmed its interest in Sigma Healthcare to 8.24% from 10.64%, according to an exchange filing on Monday.
(Reporting by Sneha Kumar in Bengaluru; Editing by Mrigank Dhaniwala)
((Sneha.Kumar@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.